Atlas Trials

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Clinical trial NCT03267264 · COMPLETED

Trial details

NCT number
NCT03267264
Sponsor
Becton, Dickinson and Company
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes
Start date
2017-09-01
Primary completion
2018-04-24
Enrollment
248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.